Enter your login e-mail to the account
Search
- Případ čerstvé těžké akutní mánie s psychotickými příznaky
MUDr. Jaroslav Poláček
(6/2004, Case reports ) - CHILDREN DEMENTIA
MUDr. Mgr. Zlata Baraníková
(3/2005, Review articles )
- Multiple sclerosis secondary progressive form – diagnostic and treatment options
doc. MUDr. Jarmila Szilasiová, PhD.
(1/2020, Review articles ) - Laboratory biomarkers of multiple sclerosis
MUDr. Kamila Žondra Revendová, Ph.D., MUDr. Ing. David Zeman, Ph.D., MUDr. Radovan Bunganič, MUDr. Kryštof Damián Švub, MUDr. Ondřej Pelíšek, doc. RNDr. Pavlína Kušnierová, Ph.D.
(1/2026, Main topic ) - Myoklonus – srovnání účinnosti léčby podle typu ovlivněných neurotransmiterových systémů
doc. MUDr. Martin Bareš, Ph.D., MUDr. Miroslava Muchová, doc. MUDr. Petr Kaňovský, CSc., prof. MUDr. Ivan Rektor, CSc.
(1/2006, Case reports ) - Myoklonus
MUDr. Martina Bočková, MUDr. Marek Baláž, Ph.D.
(1/2011, Main topic ) - New in pharmacotherapy of dementia
MUDr. Martin Vališ, Ph.D., MUDr. Dita Kalnická
(1/2011, Review articles ) - Improved cognitive function and employment in patients with relapsing multiple sclerosis treated with ocrelizumab
MUDr. Marek Peterka
(4/2023, Review articles ) - Slovo úvodem
prof. MUDr. Ivan Rektor, CSc.
(5/2006, Editorial ) - Ocrelizumab – what we know, what we can improve now, what we can improve in the future
MUDr. Martin Elišák, Ph.D.
(1/2024, Review articles ) - Ofatumumab in clinical practice
MUDr. Martin Elišák, Ph.D.
(1/2024, Review articles ) - Efficacy and safety of ofatumumab in naive MS patients.
MUDr. Martina Martiníková
(5/2023, Informations ) - Evaluating the efficacy of treatment for multiple sclerosis in the practice; development of the NEDA concept
prof. MUDr. Eva Kubala Havrdová, DrSc.
(3/2025, Main topic ) - Brain atrophy and multiple sclerosis: theory and clinical practice
MUDr. Martin Karlík, PhD., MUDr. Peter Mikula
(3/2025, Informations ) - Parkinsonian syndrome induced by long-term manganese exposure
prof. MUDr. Petr Kaňovský, CSc., MUDr. Kateřina Menšíková, MUDr. David Franc, MUDr. Petra Smolková
(2/2013, Case reports ) - Ocrelizumab, clinical aktivity and progression – long-term data
MUDr. Zbyšek Pavelek, PhD., doc. MUDr. Martin Vališ, Ph.D.
(3/2019, Pharmacotherapy ) - B-cell targeted therapy to impact the progression of multiple sclerosis
MUDr. Martin Elišák, Ph.D.
(3/2023, Review articles ) - Neurofilament light chain (NfL) and glial fibrillary acid protein (GFAP) as biomarkers disease activity and therapeutic response in multiple sclerosis treated with ocrelizumab
prof. MUDr. Pavel Štourač, Ph.D.
(3/2026, Trends in neuropharmacotherapy ) - Ocrelizumab and novel therapeutic goals in multiple sclerosis
MUDr. Radek Ampapa
(2/2020, Review articles )